DA
Derek Archila Wells Fargo Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
64
Avg Return
Past Year
Past Year
17%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
56.1%
Neutral
43.9%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Energy
Healthcare
Energy
Oil & Gas Midstream
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Overweight
Maintained
| $756 |
18%
downside
| 3 | +16% |
0
%
| 31 Jul ‘25 3 months ago |
|
|
|
Overweight
Initiated
| $17 |
123%
upside
| 1 | +98% |
0
%
| 25 Jul ‘25 4 months ago |
|
|
|
Overweight
Maintained
| $129 |
20%
upside
| 2 | +55% |
0
%
| 10 Jul ‘25 4 months ago |
|
|
|
Equal-Weight
Downgraded
| $129 |
0%
downside
| 1 | +44% |
–
| 17 Jun ‘25 5 months ago |
|
|
|
Equal-Weight
Maintained
| $15 |
628%
upside
| 2 | – |
–
| 12 Mar ‘25 8 months ago |
|
|
|
Equal-Weight
Maintained
| $14 |
49%
downside
| 1 | – |
–
| 19 Dec ‘24 11 months ago |
|
|
|
Overweight
Maintained
| $45 |
90%
upside
| 1 | -9.7% |
0
%
| 19 Dec ‘24 11 months ago |
|
|
|
Overweight
Maintained
| $13 |
473%
upside
| 1 | -44% |
0
%
| 11 Dec ‘24 11 months ago |
|